Novartis has gotten their pointless direct renin inhibitor approved by the European equivalent of the FDA.
How utterly snooze-worthy. Now you Europeans can waste your
tax dollars money on the drug, too! Hooray!
Bonus Tekturna story:
Doctor writes a prescription for Tekturna for one of his patients. (One of our drug delivery guys, actually.) Gives him a free sample card, even though he doesn’t have insurance and thinks he’s doing him a favor. He gets 30 Tekturna for free, and the next month rolls around. That’ll be $100, please, even with the employee discount I gave him because he amuses me.
He almost shit a brick.
Remember, folks: giving patients a FREE SAMPLE is great, but it’s a complete WASTE OF EVERYONE’S TIME if they are without insurance or if their insurance doesn’t cover it.
Mr. Delivery Guy comes back a week later with a prescription for lisinopril, after I write him a note to give to his bonehead physician.
[tags]Tekturna, aliskiren, Rasilez[/tags]
4 thoughts on “Now you Europeans can waste your money on aliskiren, too”
I tried to tell our Novartis rep that I saw no role for his new drug other than for patients who couldn’t take an ACE-I or an ARB because of angioedema/allergy. (Also said it had a stupid name) He tried to give me his spiel, but I tuned him out.
Might help if you re-read your RAAS physiology…
No, it probably wouldn’t.
You’re an idiot